Search Results - Marcelo V. Negrão

Refine Results
  1. 1
    BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape

    BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape by David Planchard, Rachel E. Sanborn, Marcelo V. Negrão, Aria Vaishnavi, Egbert F. Smit

    Published 2024
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Inpatient palliative chemotherapy is associated with high mortality and aggressive end-of-life care in patients with advanced solid tumors and poor performance status

    Inpatient palliative chemotherapy is associated with high mortality and aggressive end-of-life care in patients with advanced solid tumors and poor performance status by Vitor Fiorin de Vasconcellos, Renata Colombo Bonadio, Guilherme Avanço, Marcelo V. Negrão, Rachel P. Riechelmann

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Palliative chemotherapy for patient with advanced tumor and poor performance status: Are oncologists’ hopes of benefit justified?

    Palliative chemotherapy for patient with advanced tumor and poor performance status: Are oncologists’ hopes of benefit justified? by Vitor Fiorin de Vasconcellos, Renata R.C. Colombo Bonadio, Guilherme Avanço, Marcelo V. Negrão, Rachel P. Riechelmann

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    QUIMIOTERAPIA PALIATIVA BENEFICIA PACIENTES COM CÂNCER AVANÇADO E BAIXO PERFORMANCE?

    QUIMIOTERAPIA PALIATIVA BENEFICIA PACIENTES COM CÂNCER AVANÇADO E BAIXO PERFORMANCE? by Vitor Fiorin de Vasconcellos, Renata Rodrigues da Cunha Colombo Bonadio, Guilherme Avanço, Marcelo V. Negrão, Paulo M. Hoff, Rachel P. Riechelmann

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Immature Uterine Teratoma Associated with Uterine Inversion

    Immature Uterine Teratoma Associated with Uterine Inversion by Karla Teixeira Souza, Marcelo V. Negrão, Lucila Soares da Silva Rocha, Giovanni Favero, Samantha Cabral Severino da Costa, Maria Del Pilar Estevez-Diz

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    A retrospective study of chemoradiotherapy (CRT) versus chemotherapy (CT) as adjuvant treatment for localized gastric cancer (LGC)

    A retrospective study of chemoradiotherapy (CRT) versus chemotherapy (CT) as adjuvant treatment for localized gastric cancer (LGC) by Daniel M. Girardi, Gabriel Clemente de Brito Pereira, Marcelo V. Negrão, M.A. Lima, Marcelo Felizola, Rodrigo Nogueira Fogace, Fernanda Capareli, Jorge Sabbaga, Paulo M. Hoff

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis

    Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis by Daniel M. Girardi, Mariana A. de Lima, Gabriel Clemente de Brito Pereira, Marcelo V. Negrão, Rossana Verónica Mendoza López, Fernanda Capareli, Jorge Sabbaga, Paulo M. Hoff

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    COMPARAÇÃO EM MODELO DE “PROPENSITY SCORE” ENTRE QUIMIORRADIOTERAPIA E QUIMIOTERAPIA NO TRATAMENTO ADJUVANTE DO CÂNCER GÁSTRICO LOCALIZADO

    COMPARAÇÃO EM MODELO DE “PROPENSITY SCORE” ENTRE QUIMIORRADIOTERAPIA E QUIMIOTERAPIA NO TRATAMENTO ADJUVANTE DO CÂNCER GÁSTRICO LOCALIZADO by Daniel M. Girardi, Mariana Arroxelas Galvão de Lima, Marcelo V. Negrão, Gabriel Clemente de Brito Pereira, Rossana Verónica Mendoza López, Fernanda Capareli, Jorge Sabbaga, Paulo M. Hoff

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    AMPLIFICAÇÃO DE EGFR COMO NOVO MECANISMO DE RESISTÊNCIA IDENTIFICADO EM BIÓPSIAS LÍQUIDAS SERIADAS DURANTE O USO DE OSIMERTINIBE EM CARCINOMA DE PULMÃO NÃO PEQUENAS CÉLULAS (CPNPC) - RELATO DE UM CASO

    AMPLIFICAÇÃO DE EGFR COMO NOVO MECANISMO DE RESISTÊNCIA IDENTIFICADO EM BIÓPSIAS LÍQUIDAS SERIADAS DURANTE O USO DE OSIMERTINIBE EM CARCINOMA DE PULMÃO NÃO PEQUENAS CÉLULAS (CPNPC)... by Bruna Migliavacca Zucchetti, Franciele Hinterholz Knebel, Fabiana Bettoni, Andrea Kazumi Shimada, Manuel Cruz, Joao V. Alessi, Marcelo V. Negrão, Luiz F. L. Reis, Artur Katz, Anamaria A. Camargo

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With <i>KRAS<sup>G12C</sup></i>-Mutated Non–Small-Cell Lung Cancer Who Have Untreated CNS Metastases

    Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With <i>KRAS<sup>G12C</sup></i>-Mutated Non–Small-Cell Lung Cancer Who Have Untreated CNS Metastases by Marcelo V. Negrão, Alexander I. Spira, Rebecca S. Heist, Pasi A. Jänne, Jose M. Pacheco, Jared Weiss, Shirish M. Gadgeel, Karen Velastegui, Wenjing Yang, Hirak Der‐Torossian, James G. Christensen, Joshua K. Sabari

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives

    Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives by Jay M. Lee, Ciaran McNamee, Eric M. Toloza, Marcelo V. Negrão, Jules Lin, Elaine Shum, Amy L. Cummings, Mark G. Kris, Boris Sepesi, Ilze Bāra, Nino Kurtsikidze, Katja Schulze, Celina Ngiam, Jamie E. Chaft

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Endothelial Nitric Oxide Synthase Polymorphisms and Adaptation of Parasympathetic Modulation to Exercise Training

    Endothelial Nitric Oxide Synthase Polymorphisms and Adaptation of Parasympathetic Modulation to Exercise Training by Bruno M. Silva, Fabricia J. Neves, Marcelo V. Negrão, Cléber R. Alves, Rodrigo Gonçalves Dias, Guilherme B. Alves, Alexandre C. Pereira, Maria Urbana Pinto Brandão Rondon, José Eduardo Krieger, Carlos Eduardo Negrão, Antônio Cláudio Lucas da Nóbrega

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Aerobic Exercise Training Combined with Local Strength Exercise Restores Muscle Blood Flow and Maximal Aerobic Capacity in Long-Term Hodgkin Lymphoma Survivors

    Aerobic Exercise Training Combined with Local Strength Exercise Restores Muscle Blood Flow and Maximal Aerobic Capacity in Long-Term Hodgkin Lymphoma Survivors by Luciana de Souza dos Santos, Marília Harumi Higuchi dos Santos Rehder, Marcelo V. Negrão, Beatriz R. Goes‐Santos, Edgar Toschi‐Dias, Camila Jordão Paixão, Úrsula Urias, Natali Schiavo Giannetti, Ludhmila Abrahão Hajjar, Roberto Kalil Filho, Carlos Eduardo Negrão

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Adjuvant Treatment with 5-Fluorouracil and Oxaliplatin Does Not Influence Cardiac Function, Neurovascular Control, and Physical Capacity in Patients with Colon Cancer

    Adjuvant Treatment with 5-Fluorouracil and Oxaliplatin Does Not Influence Cardiac Function, Neurovascular Control, and Physical Capacity in Patients with Colon Cancer by Raphaela V. Groehs, Marcelo V. Negrão, Ludhmila Abrahão Hajjar, Camila Paixão Jordão, Bruna Carvalho, Edgar Toschi‐Dias, Ana Andrade, Fabiana P. Hodas, Maria Janieire de Nazaré Nunes Alves, Adriana Sarmento de Oliveira, Laura Testa, Paulo M. Hoff, Carlos Eduardo Negrão, Roberto Kalil Filho

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    <i>STK11</i>/LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase Inhibition

    <i>STK11</i>/LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase Inhibition by Piyada Sitthideatphaiboon, Ana Galán‐Cobo, Marcelo V. Negrão, Xiao Qu, Alissa Poteete, Fahao Zhang, Diane D. Liu, Whitney E. Lewis, Haley N. Kemp, Jeff Lewis, Waree Rinsurongkawong, Uma Giri, J. Jack Lee, Jianjun Zhang, Jack A. Roth, Stephen G. Swisher, John V. Heymach

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Poziotinib for Patients With <i>HER2</i> Exon 20 Mutant Non–Small-Cell Lung Cancer: Results From a Phase II Trial

    Poziotinib for Patients With <i>HER2</i> Exon 20 Mutant Non–Small-Cell Lung Cancer: Results From a Phase II Trial by Yasir Y. Elamin, Jacqulyne Robichaux, Brett W. Carter, Mehmet Altan, Don L. Gibbons, Frank V. Fossella, Vincent K. Lam, Anisha B. Patel, Marcelo V. Negrão, Xiuning Le, Frank E. Mott, Jianjun Zhang, Lei Feng, George R. Blumenschein, Anne S. Tsao, John V. Heymach

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Breast Cancer Promotes Cardiac Dysfunction Through Deregulation of Cardiomyocyte Ca <sup>2+</sup> ‐Handling Protein Expression That is Not Reversed by Exercise Training

    Breast Cancer Promotes Cardiac Dysfunction Through Deregulation of Cardiomyocyte Ca <sup>2+</sup> ‐Handling Protein Expression That is Not Reversed by Exercise Training by Tassia Santos Rodrigues da Costa, Úrsula Urias, Marcelo V. Negrão, Camila Paixão Jordão, Clévia Santos Passos, Igor L. Gomes‐Santos, Vera Maria Cury Salemi, Anamaria A. Camargo, Patrı́cia C. Brum, Edilamar Menezes de Oliveira, Ludhmila Abrahão Hajjar, Roger Chammas, Roberto Kalil Filho, Carlos Eduardo Negrão

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non–Small Cell Lung Cancer

    PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non–Small Cell... by Marcelo V. Negrão, Vincent K. Lam, Alexandre Reuben, Maria Laura Rubin, L.L. Landry, Emily Roarty, Waree Rinsurongkawong, Jeff Lewis, Jack A. Roth, Stephen G. Swisher, Don L. Gibbons, Ignacio I. Wistuba, Vassiliki A. Papadimitrakopoulou, Bonnie S. Glisson, George R. Blumenschein, J. Jack Lee, John V. Heymach, Jianjun Zhang

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Chemotherapy acutely impairs neurovascular and hemodynamic responses in women with breast cancer

    Chemotherapy acutely impairs neurovascular and hemodynamic responses in women with breast cancer by Allan R. K. Sales, Marcelo V. Negrão, Laura Testa, Larissa Ferreira‐Santos, Raphaela Villar Ramalho Groehs, Bruna Carvalho, Edgar Toschi‐Dias, Natália G. Rocha, Francisco Rafael Martins Laurindo, Victor Debbas, Maria Urbana Pinto Brandão Rondon, Max Sena Mano, Ludhmila Abrahão Hajjar, Paulo M. Hoff, Roberto Kalil Filho, Carlos Eduardo Negrão

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    OA02.06 A Phase II Trial of Poziotinib in EGFR and HER2 exon 20 Mutant Non-Small Cell Lung Cancer (NSCLC)

    OA02.06 A Phase II Trial of Poziotinib in EGFR and HER2 exon 20 Mutant Non-Small Cell Lung Cancer (NSCLC) by John V. Heymach, Marcelo V. Negrão, Jacqulyne Robichaux, B. Carter, Ami Patel, Mehmet Altan, Don L. Gibbons, Frank V. Fossella, George R. Simon, Vincent K. Lam, George R. Blumenschein, Anne S. Tsao, Jonathan M. Kurie, Frank E. Mott, David W. Jenkins, David H. Mack, Lei Feng, Brent Roeck, Zane Yang, V. Papadimitrakopoulou, Yasir Y. Elamin

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: